Morgan Stanley Maintains Equal-Weight on argenx, Raises Price Target to $278
Morgan Stanley maintains argenx (NASDAQ:ARGX) with a Equal-Weight and raises the price target from $274 to $278.
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
Morgan Stanley Maintains Equal-Weight on argenx, Lowers Price Target to $274
Morgan Stanley maintains argenx (NASDAQ:ARGX) with a Equal-Weight and lowers the price target from $339 to $274.
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker’s Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
Morgan Stanley Maintains Equal-Weight on argenx, Lowers Price Target to $339
Morgan Stanley maintains argenx (NASDAQ:ARGX) with a Equal-Weight and lowers the price target from $351 to $339.
What 8 Analyst Ratings Have To Say About argenx
Within the last quarter, argenx (NASDAQ:ARGX) has observed the following analyst ratings:
65 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
Raymond James Maintains Strong Buy on argenx, Raises Price Target to $455
Raymond James analyst Danielle Brill maintains argenx (NASDAQ:ARGX) with a Strong Buy and raises the price target from $390 to $455.
Credit Suisse Maintains Neutral on argenx, Raises Price Target to $340
Credit Suisse analyst Tiago Fauth maintains argenx (NASDAQ:ARGX) with a Neutral and raises the price target from $297 to $340.
